奥莫康唑是一种新型的咪唑类衍生物。在体外,它对广泛的临床新近分离的酵母菌与标本菌株有较强活性,并已显示其抑制真菌的作用较酮康唑、两性霉素乙、制霉菌素及灰黄霉素强。在同一稀释度内也可与疏康唑、咪康唑、益康唑的活性相比。奥莫康唑也显示出抗G细菌的高度活性。它对豚鼠实验性毛发癣菌属须疮菌感染也有效。1%奥莫康唑霜在所有病例中的延迟性抗真菌效果至少达48h。国际多中心试验研究了1%奥莫康唑每日 Oxymorconazole is a novel imidazole derivative. In vitro, it has strong activity against a wide range of clinically isolated yeast and specimen strains and has been shown to exert a stronger fungistatic effect against ketoconazole, amphotericin B, nystatin and griseofulvin. In the same dilution also with the activity of sparoconazole, miconazole, econazole compared. Oxymorconazole also shows a high degree of activity against G-bacteria. It is also effective against guinea pig experimental Trichophyton mentagrophytes infection. The delayed antifungal effect of 1% of omconconazole cream in all cases was at least 48 h. The international multicenter trial studied 1% of omconazole daily